DaVita Projects 50.6% Quarterly EPS Growth at 12.15x Forward Earnings Multiple
Question
DaVita Projects 50.6% Quarterly EPS Growth at 12.15x Forward Earnings Multiple
Direct answer
DaVita HealthCare demonstrated relative strength ahead of its upcoming earnings report, rising 1.26% to $179.25. The dialysis provider is forecast to generate 50.6% year-over-year EPS growth despite modest 3.23% topline expansion. A forward valuation multiple of 12.15x reflects market caution on reimbursement rates, yet full-year earnings estimates indicate 35.16% expansion supported by cost containment and treatment volume stability.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-11
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “DaVita Projects 50.6% Quarterly EPS Growth at 12.15x Forward Earnings Multiple”, revision 1, evidence through 2026-10-11. https://marketontology.com/market-events/2026-10-11/davita-projects-50-6-quarterly-eps-growth-at-12-15x-forward-earnings-multiple-122aed
How this development reaches the affected companies
| Asset | Exposure and channel | Direction | Evidence |
|---|---|---|---|
| DVA | operating leverage and treatment volume margin expansion | Up1-4w | DaVita projected to report 50.6% EPS growth on 12.15x forward P/E. |
Does this development affect your holdings?
Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
What happened next
Price follow-up pending — no stored daily closes for these assets yet.
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related
- 2026-10-11DaVita Outperforms S&P 500 on Projected 50.6% Dialysis EPS ExpansionDVA
- 2026-10-11DaVita Outperforms S&P 500 on Projected 50.6% Dialysis EPS ExpansionDVA XLV+3.45%
- 2026-10-10DaVita Outpaces S&P 500 on Forecast 50.6 Percent Quarterly EPS GrowthDVA SPY-1.97%
- 2026-10-10DaVita Gains 1.3% to $179.25 with Q3 EPS Projected Up 50.6% YoYDVA
- 2026-10-10DaVita Gains as Forward P/E Holds at 12.15x Against 50.6% Projected EPS GrowthDVA
- 2026-10-10DaVita Gains as Forward P/E Holds at 12.15x Against 50.6% Projected EPS GrowthDVA
- 2026-10-10DaVita Outpaces S&P 500 on Forecast 50.6 Percent Quarterly EPS GrowthDVA SPY-1.97%
- 2026-10-10DaVita Gains as Forward P/E Holds at 12.15x Against 50.6% Projected EPS GrowthDVA
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.